Takeda Pharmaceutical Company Limited Share Price NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.56 USD | -0.30% |
|
-1.25% | +6.22% |
| 07-08 | Takeda Pharmaceutical Completes Share Issuance, Disposal Under Incentive Plan | MT |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| Market Cap | 8,467B 52.33B 45.87B 42.19B 39.07B 74.07B 4,993B 75.31B 502B 198B 2,463B 197B 192B | P/E 2027 * |
43.6x | P/E 2028 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12,352B 76.35B 66.92B 61.55B 57.01B 108B 7,284B 110B 732B 289B 3,594B 287B 281B | EV / Sales 2027 * |
2.67x | EV / Sales 2028 * | 2.6x |
| Free-Float |
99.26% | Yield 2027 * |
3.81% | Yield 2028 * | 3.89% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.30% | ||
| 1 week | -1.25% | ||
| Current month | +3.31% | ||
| 1 month | +5.61% | ||
| 3 months | -8.41% | ||
| 6 months | +1.53% | ||
| Current year | +6.22% |
| 1 week | 16.51 |  | 17.12 |
| 1 month | 15.34 | | 17.12 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | -1.25% | - | - | 52.42B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -1.09% | -3.25% | +24.40% | +55.51% | 397.1B | |
| Weighted average by Cap. | -1.30% | -2.96% | +35.28% | +81.27% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.62B 25.09B 23.07B 21.37B 40.51B 2,730B 41.19B 274B 108B 1,347B 108B 105B | 4,701B 29.06B 25.47B 23.42B 21.69B 41.13B 2,772B 41.81B 279B 110B 1,368B 109B 107B |
| Net income | 184B 1.14B 996M 916M 849M 1.61B 108B 1.64B 10.9B 4.3B 53.51B 4.27B 4.18B | 309B 1.91B 1.68B 1.54B 1.43B 2.71B 182B 2.75B 18.33B 7.23B 89.99B 7.18B 7.03B |
| Net Debt | 3,886B 24.02B 21.05B 19.36B 17.93B 33.99B 2,291B 34.56B 230B 90.81B 1,131B 90.23B 88.27B | 3,750B 23.18B 20.32B 18.69B 17.31B 32.81B 2,212B 33.36B 222B 87.65B 1,091B 87.09B 85.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$16.56 | -0.30% | 1,503,758 |
| 09/07/26 | US$16.61 | -0.84% | 2,392,967 |
| 08/07/26 | US$16.75 | -1.24% | 2,241,547 |
| 07/07/26 | US$16.96 | +0.41% | 2,654,300 |
| 06/07/26 | US$16.89 | +0.72% | 2,883,396 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
